EE214 Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States
Abstract
Authors
Ahmead S. Baljoon Islam Eljilany Karam Diaby Askal Ayalew Ali Sandra Suther Matthew Dutton